Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2014.

The company has posted a net loss of Rs 317.62 crore for the quarter under review as compared to a net profit of Rs 6.30 crore for the same quarter in the previous year. Total income of the company has decreased 16.03% at Rs 540.54 crore for Q2FY15 as compared Rs 643.74 crore for the corresponding quarter previous year.

On consolidated basis, the company’s net profit after taxes and minority interest for the quarter under review registered 15.43% growth at Rs 1572.46 crore against Rs 1362.30 crore in the September quarter of previous fiscal. The company’s total income has increased by 11.84% at Rs 4822.15 crore for the quarter from Rs 4311.63 crore in the similar quarter of previous year.

Pharmalucence Inc., a pharmaceutical company, incorporated in United States of America became a subsidiary of the company on July 16, 2014. Accordingly, the above results for the current periods include the relevant results of Pharmalucence Inc., from the date it became subsidiary of the company and therefore the corresponding figures for the previous periods are not comparable.